Quality Improvement Intervention for Reduction of Redundant Testing.
Document Type
Article
Publication Date
1-1-2017
Publication Title
Acad Pathol
Abstract
Laboratory data are critical to analyzing and improving clinical quality. In the setting of residual use of creatine kinase M and B isoenzyme testing for myocardial infarction, we assessed disease outcomes of discordant creatine kinase M and B isoenzyme +/troponin I (-) test pairs in order to address anticipated clinician concerns about potential loss of case-finding sensitivity following proposed discontinuation of routine creatine kinase and creatine kinase M and B isoenzyme testing. Time-sequenced interventions were introduced. The main outcome was the percentage of cardiac marker studies performed within guidelines. Nonguideline orders dominated at baseline. Creatine kinase M and B isoenzyme testing in 7496 order sets failed to detect additional myocardial infarctions but was associated with 42 potentially preventable admissions/quarter. Interruptive computerized soft stops improved guideline compliance from 32.3% to 58% (
Volume
4
First Page
2374289517707506
Last Page
2374289517707506
Recommended Citation
Ducatman AM, Tacker DH, Ducatman BS, Long D, Perrotta PL, Lawther H, Pennington K, Lander O, Warden M, Failinger C, Halbritter K, Pellegrino R, Treese M, Stead JA, Glass E, Cianciaruso L, Nau KC. Quality Improvement Intervention for Reduction of Redundant Testing. Acad Pathol. 2017 May 28;4:2374289517707506. doi: 10.1177/2374289517707506. PMID: 28725791; PMCID: PMC5497914.
DOI
10.1177/2374289517707506
ISSN
2374-2895
PubMed ID
28725791
